Furthermore, the interaction of platelet and tumor cells can activate the TGF-β/Smad and NF-κB pathways in malignant cells, and further enhance the aggressiveness of tumor cells via epithelial-mesenchymal transition (EMT) (33–35). Here, TGFB1 is linked to neoplasm.